Novartis, Vasella Cancel Non-Compete, $78M Pay Deal

Feb. 19 (Bloomberg) -- Bloomberg's Caroline Hyde reports that Novartis AG announced an agreement between its board and its outgoing chairman, Daniel Vasella, to cancel a payment of a maximum of $78 million over six years to keep him from working for rival drugmakers. She speaks on Bloomberg Television's "Countdown."
Is Musk's Model S Referral Program a Warning Sign?
12:27 - Elon Musk is looking to boost Tesla sales with a little help from his friends. Tesla Motors will provide discounts when an owner recommends a Model S to a new buyer. It’s the first incentive program for the company, which eschews traditional advertising and dealer networks. Bloomberg's Dana Hull has more on "Bloomberg Markets." (Source: Bloomberg)
  • The IUD Revolution of Warren Buffett: Feminist Icon?
  • Debris Found on Island May Be From Missing Jet
  • Russia's Terrible Bet on the Euro and Gold